Plus Therapeutics (PSTV) Interest & Investment Income (2011 - 2026)
Plus Therapeutics (PSTV) reported Interest & Investment Income of $190000.0 for Q1 2026, up 18900.0% year-over-year from N/an in Q1 2025, and up 555.17% quarter-over-quarter from $29000.0 in Q4 2025.
Plus Therapeutics (PSTV) Interest & Investment Income (2011 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has 16 years of Interest & Investment Income data on file, last reported at $190000.0 in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $190000.0, up 18900.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $305000.0 (up 50.99% YoY), and the FY2025 annual result was $116000.0, down 57.51% from the prior year.
- Interest & Investment Income advanced to $190000.0 in Q1 2026 per PSTV's latest filing, from $29000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $190000.0 in Q1 2026 and troughed at $1000.0 in Q1 2025.
- A 5-year average of $66235.3 and a median of $59000.0 in 2025 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2025 and 2026: Interest & Investment Income tumbled 98.61% in 2025, then surged 18900.0% in 2026.
- A 5-year view of Interest & Investment Income shows it stood at $73000.0 in 2022, then jumped by 50.68% to $110000.0 in 2023, then plunged by 50.91% to $54000.0 in 2024, then slumped by 46.3% to $29000.0 in 2025, then jumped by 555.17% to $190000.0 in 2026.
- Business Quant data shows PSTV's Interest & Investment Income at $190000.0 in Q1 2026, $29000.0 in Q4 2025, and $59000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -14.79 Mn |
| 10 | Plus Therapeutics | 37.48 Mn | 22.37 Mn | - | 190,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 190,000.00 |
| Dec 31, 2025 | 29,000.00 |
| Sep 30, 2025 | 59,000.00 |
| Jun 30, 2025 | 27,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 54,000.00 |
| Sep 30, 2024 | 80,000.00 |
| Jun 30, 2024 | 67,000.00 |
| Mar 31, 2024 | 72,000.00 |
| Dec 31, 2023 | 110,000.00 |
| Sep 30, 2023 | 119,000.00 |
| Jun 30, 2023 | 120,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | 73,000.00 |
| Sep 30, 2022 | 48,000.00 |
| Jun 30, 2022 | 19,000.00 |
| Mar 31, 2022 | 7,000.00 |
| Dec 31, 2021 | 6,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 4,000.00 |